Subsequent studies have supported the importance of TGR5 as a key regulator of energy expenditure, thanks to the demonstration that TGR5 mice −/− show significant weight gain and fat accumulation (56) and that the administration of a TGR5 agonist to wild mice reduces obesity and glucose levels (57). Here, GPBAR1 is linked to obesity due to melanocortin 4 receptor deficiency.